Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1: A meaningful and independent marker to predict stroke in the Chinese population

Journal of Molecular Neuroscience

Volumn 52, Issue 4, 2014, Pages 507-514

  Tu, Wen Jun ^a   Liu, Xiao Ye ^b   Dong, Hao ^c   Yu, Yan ^c   Wang, Yi ^c   Chen, Hui ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CHINA REHABILITATION RESEARCH CENTER   (China)

Author keywords

Acute ischemic stroke; Chinese; Phosphatidylinositol 3,4,5 trisphosphate 5 phosphatase 1; Risk

Indexed keywords

BIOLOGICAL MARKER; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE A; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 5 PHOSPHATASE 1; PROTEOME; SOMATOMEDIN C; UNCLASSIFIED DRUG; GENETIC MARKER; INOSITOL-POLYPHOSPHATE 5-PHOSPHATASE;

ADULT; AGED; ANTIBODY AFFINITY; ARTICLE; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; PREDICTIVE VALUE; STROKE PATIENT; TANDEM MASS SPECTROMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; EPIDEMIOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICS AND NUMERICAL DATA; STROKE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHOSPHORIC MONOESTER HYDROLASES; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; STROKE;

EID: 84899491630     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0206-2     Document Type: Article

References (36)

1. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35-41
2. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521-1526
3. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsanl WG et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-870
4. Cai Z, Semenza GL (2004) Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury. Circulation 109:2050-2053
5. Cairns DA (2011) Statistical issues in quality control of proteomic analyses: good experimental design and planning. Proteomics 11:1037-1048
6. Daigle I, Yousefi S, Colonna M, Green DR, Simon HU (2002) Death receptors bind SHP-1 and block cytokine-induced anti-apoptotic signaling in neutrophils. Nat Med 8:61-67
7. Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5:e123
8. Fahlman RP, Chen W, Overall CM (2013) Absolute proteomic quantification of the activity state of proteases and proteolytic cleavages using proteolytic signature peptides and isobaric tags. J Proteomics. doi:10.1016/j.jprot.2013.09. 006
9. Fatima N, Chelius D, Luke BT et al (2009) Label-free global serum proteomic profiling reveals novel celecoxib-modulated proteins in familial adenomatous polyposis patients. Cancer Genomics Proteomics 6:41-49
10. Fernandes S, Iyer S, Kerr WG (2013) Role of SHIP1 in cancer and mucosal inflammation. Ann N Y Acad Sci 1280:6-10
11. Freeburn RW, Wright KL, Burgess SJ, Astoul E, Cantrell DA et al (2002) Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J Immunol 169:5441-5450
12. Ghansah T, Paraiso KH, Highfill S, Desponts C, May S, McIntosh JK, Wang JW, Ninos J, Brayer J, Cheng F, Sotomayor E, Kerr WG (2004) Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J Immunol 173:7324-7330
13. Hanash SM, Pitteri SJ, Faca VM (2008) Mining the plasma proteome for cancer biomarkers. Nature 452:571-579
14. Hetman M, Kanning K, Cavanaugh JE et al (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274:22569-22580
15. Hideshima S, Sato R, Inoue S et al (2012) Detection of tumor marker in blood serum using antibody-modified field effect transistor with optimized BSA blocking. Sensors Actuators B Chem 161:146-150
16. Hirukawa AM (2011) The role of SHIP1 in modulating disease severity in the K/BxN serum transfer model of rheumatoid arthritis. University of British Columbia
17. Johnston SC, Mendis S, Mathers CD (2009) Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modeling. Lancet Neurol 8:345-354
18. Kang X, Sun L, Guo K, Shu H, Yao J, Qin X, Liu Y (2010) Serumprotein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS. J Cancer Res Clin Oncol 136(8):1151-1159
19. Kiga C, Sakurai H, Goto H et al (2008) Proteomic identification of haptoglobin as a stroke plasma biomarker in spontaneously hypertensive stroke-prone rats. Life Sci 83:625-631
20. Kilic E, Kilic Ü, Wang Y et al (2006) The phosphatidylinositol-3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. The FASEB J 20(8):1185-1187
21. Levin Y, Schwarz E, Wang L et al (2007) Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J Sep Sci 30:2198-2203
22. Liu Q, Sasaki T, Kozieradzki I, Wakeham A, Itie A et al (1999) SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival. Genes Dev 13:786-791
23. Matsui T, Li L, del Monte F et al (1999) Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro. Circulation 100:2373-2379
24. Nahnsen S, Bielow C, Reinert K et al (2013) Tools for label-free peptide quantification. Mol Cell Proteomics 12:549-556
25. Radulovic D, Jelveh S, Ryu S, Hamilton TG, Foss E, Mao Y, Emili A (2004) Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 3:984-997
26. Richards TJ, Kaminski N, Baribaud F et al (2012) Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 185:67-76
27. Roongapinun S, Oh SY, Wu F et al (2010) Role of SHIP-1 in the adaptive immune responses to aeroallergen in the airway. PloS One 5(11):e14174
28. Silva JC, Gorenstein MV, Li GZ, Vissers JPC, Geromanos SJ (2006) Absolute quantification of proteins by LCMSE. A virtue of parallel MS acquisition. Mol Cell Proteomics 5:144-156
29. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES (2009) ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 72:2104-2110
30. Tarasenko T, Kole HK, Chi AW, Mentink-Kane MM, Wynn TA et al (2007) T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc Natl Acad Sci U S A 104:11382-11387
31. Tu WJ, Dong X, Zhao SJ et al (2013) Prognostic value of plasma neuroendocrine biomarkers in patients with acute ischemic stroke. J Neuroendocrinol 25:771-778
32. Tu WJ, Zhao SJ, Xu DJ et al (2014) Serum 25-hydroxyvitamin D predicts the short-term outcomes of Chinese patients with acute ischemic stroke. Clin Sci 126:339-346
33. Vissers JPC, Langridge JI, Aerts JMFG (2007) Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics 6:755-766
34. Wiener MC, Sachs JR, Deyanova EG, Yates NA (2004) Differential mass spectrometry: a label-free LC-MS method for finding differences in complex peptide and protein mixtures. Anal Chem 76:6085-6096
35. Zeng X, Hood BL, Zhao T et al (2011) Lung cancer serum biomarker discovery using label free LC-MS/MS. J Thorac Oncol 6(4):725-734
36. Zhu W, Smith JW, Huang CM (2010) Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010:840518